Drug-induced nasal septum perforation: a disproportionality analysis of the FDA adverse event reporting system database
This study provides a comprehensive overview of drug-induced nasal septum perforation from a pharmacovigilance perspective, highlighting the need for further research to clarify these associations and update drug safety information to reduce patient risk.
Authors
- Qianhui Qiu (ORCID: https://orcid.org/0000-0001-6335-5173)
- Suizi Zhou (ORCID: https://orcid.org/0000-0002-8457-6044)
- Zhilin Jiang (ORCID: https://orcid.org/0000-0002-6135-0915)
- Congying Xie (ORCID: https://orcid.org/0000-0002-1693-9034)
- Yitong Liu (ORCID: https://orcid.org/0000-0002-4300-4349)
- Yi Cui (ORCID: https://orcid.org/0000-0003-0619-956X)
- Yuewu Wang (ORCID: https://orcid.org/0009-0003-5170-1253)
- Kun Wang (ORCID: https://orcid.org/0000-0003-4221-2485)
- Fang Sun
Institutions
- Guangdong Academy of Medical Sciences (CN)
- Chenzhou First People's Hospital (CN)
- Guangdong Provincial People's Hospital (CN)
- Southern Medical University (CN)
Publication Details
- Journal
- Expert Opinion on Drug Safety
- Published
- 2025-02-01
- DOI
- https://doi.org/10.1080/14740338.2025.2460448
- Primary Topic
- Pharmacovigilance and Adverse Drug Reactions
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China